Montreal Cognitive Assessment (MoCA) Score Calculator

Calculate Montreal Cognitive Assessment (MoCA) scores across 8 cognitive domains to screen for mild cognitive impairment and dementia. Education adjustment and domain breakdown included.

MoCA Score
Cognitive Classification
Weakest Domain
Extended More scenarios, charts & detailed breakdown
Raw Total (before education adj.)
Memory (Delayed Recall) %
Executive/Visuospatial %
Attention %
Professional Full parameters & maximum detail

Total Score

MoCA Score
Classification

Domain Scores

Memory (Delayed Recall)
Executive/Visuospatial
Attention Score

Clinical Workup

Suggested Workup

How to Use This Calculator

  1. Enter scores for each of the 7 MoCA domains from the completed paper test.
  2. Select whether patient has ≤12 years of education for the 1-point adjustment.
  3. Total score, classification, and weakest domain appear instantly.
  4. Domain Scores tab: percentage breakdown per domain.
  5. Professional tier: full domain analysis with suggested diagnostic workup.

Formula

MoCA score = Visuospatial(5) + Naming(3) + Attention(6) + Language(3) + Abstraction(2) + Delayed Recall(5) + Orientation(6) + Education adjustment(1). Max: 30. Normal: ≥26.

Example

Domains: 4+3+5+2+2+3+6 = 25 + 0 (>12yrs education) = 25 → Mild cognitive impairment. MCI workup indicated.

Frequently Asked Questions

  • The Montreal Cognitive Assessment (MoCA) is a brief, validated cognitive screening instrument developed by Dr. Ziad Nasreddine and colleagues, first published in the Journal of the American Geriatrics Society in 2005. It was designed to address the key limitation of the Mini-Mental State Examination (MMSE) — low sensitivity for detecting mild cognitive impairment (MCI). The MoCA requires 10–15 minutes to administer and assesses eight cognitive domains: visuospatial and executive function (5 points), naming (3 points), attention (6 points), language (3 points), abstraction (2 points), delayed recall (5 points), and orientation (6 points), for a maximum of 30 points. One bonus point is added for patients with 12 or fewer years of formal education. The cut-point for normal cognition is ≥26/30. Compared to the MMSE (a 30-point scale with cut-point ≥24), the MoCA has substantially higher sensitivity for MCI (90% vs 18%) with similar specificity. This is because the MoCA includes more executive function and attention tasks (Trail Making B, clock drawing, serial 7s, digit span backward) that are sensitive to the early cortical and prefrontal changes of MCI, whereas the MMSE is more sensitive for established dementia. Major clinical guidelines, including those from the Alzheimer's Association, recommend the MoCA as the preferred brief cognitive screening tool in memory clinic and primary care settings.
  • In the original 2005 validation study by Nasreddine and colleagues (n = 277), a MoCA score below 26 out of 30 detected MCI with 90% sensitivity and 87% specificity when compared to neuropsychological assessment as the gold standard. Normal controls averaged 27.4 ± 2.2 points; MCI patients averaged 22.1 ± 3.1 points; and Alzheimer's disease patients averaged 16.2 ± 4.8 points. In clinical practice, scores are interpreted in zones: 26–30 as normal cognition (though this should be interpreted in context for highly educated individuals who may show decline still within this range); 18–25 as mild cognitive impairment; 10–17 as moderate cognitive impairment suggestive of dementia; and below 10 as severe cognitive impairment. However, the MoCA is a screening tool, not a diagnostic instrument. A score below 26 should prompt a comprehensive dementia evaluation including detailed history, functional assessment (ADL/IADL), neurological examination, laboratory workup (TSH, B12, CBC, CMP), and neuroimaging. The minimal detectable change on the MoCA is approximately 1.22 points (95% CI), meaning a change of 2 or more points between serial tests is generally considered clinically significant and unlikely to be attributable to measurement error alone.
  • The MoCA includes a validated education adjustment: one point is added to the total score for patients who have received 12 or fewer years of formal education (i.e., completed up to secondary/high school but did not receive tertiary education). This adjustment was empirically derived from the original validation study, which showed that lower educational attainment was associated with lower scores on the MoCA independently of cognitive status, creating potential for over-detection of impairment in less-educated individuals. The adjusted score should not exceed 30 — if the raw score is already 30, no additional point is added. This educational correction is particularly important in populations with high rates of limited formal education. It is important to note that the education adjustment is a rough correction; more sophisticated normative data are available for specific age, education, and cultural groups. Population-specific normative studies (e.g., for Spanish speakers, Chinese populations, elderly populations aged 80+) have been published and should be used when available. Some researchers advocate for using age and education-stratified norms rather than a single universal cut-point, as cognitive reserve means that highly educated individuals may show clinically significant decline while still scoring above 26.
  • Different neurodegenerative and vascular diseases produce characteristic MoCA domain profiles that can assist in differential diagnosis. Alzheimer's disease (AD) typically affects episodic memory earliest and most severely — the delayed recall domain (5 words after a 5-minute delay) is characteristically the lowest scoring domain, often with 0–2 of 5 words recalled even in mild AD. The naming domain (naming a lion, rhinoceros, and camel from pictures) may also be impaired. Vascular cognitive impairment and subcortical white matter disease affect frontal-subcortical circuits and produce disproportionate impairment in executive function and attention domains (serial 7s, Trail Making B, backward digit span) with relatively preserved memory. Lewy body dementia and Parkinson's disease dementia show prominent visuospatial/executive deficits (clock drawing, cube copy) and attention fluctuation. Frontotemporal dementia (FTD) affects language (fluency, repetition) and abstraction most severely while memory may be relatively spared early. Primary progressive aphasia specifically impairs the language domain. Posterior cortical atrophy (a variant of AD) primarily affects visuospatial function. Serial MoCA testing tracking which domains decline most rapidly can provide prognostic information — rapid memory decline suggests more typical AD, while rapid executive decline suggests vascular or Lewy body pathology.
  • The COVID-19 pandemic accelerated development and validation of telephone and videoconferencing versions of the MoCA. The Telephone MoCA (T-MoCA) is an adapted version that removes items requiring visual stimuli — visuospatial tasks (Trail B, cube copy, clock drawing) and naming from pictures are removed or replaced. The T-MoCA covers attention, language, abstraction, delayed recall, and orientation for a maximum of approximately 22 points, with different cut-points validated against the standard in-person MoCA. Studies by Subramanian and colleagues (2020) found the T-MoCA strongly correlates with the standard MoCA (r = 0.76) and can classify MCI with sensitivity around 80%. The MoCA Blind (MoCA-B) was similarly developed for visually impaired patients. Videoconference-administered MoCA (tele-MoCA) using platforms like Zoom has been validated for patients who can use screens and has shown high concordance with in-person administration (Intraclass Correlation Coefficient 0.95). Tele-administration enables remote monitoring of homebound patients and those in areas with limited specialist access. Standard MoCA PDFs and digital administration apps are available at mocatest.org, which also provides training, certification, and language-specific versions. Clinicians should use language-appropriate and culturally validated versions of the MoCA for non-English-speaking patients to avoid systematic bias.

Related Calculators

Sources & References (5)
  1. Nasreddine ZS et al. — The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment (J Am Geriatr Soc 2005;53:695-699) — Journal of the American Geriatrics Society
  2. Freitas S et al. — The Montreal Cognitive Assessment: normative study for the Portuguese population (Arch Clin Neuropsychol 2011) — Archives of Clinical Neuropsychology
  3. Carson N et al. — Reliability and validity of the cognitive assessment of older adults (Prim Care Companion J Clin Psychiatry 2018) — Primary Care Companion
  4. Julayanont P & Nasreddine ZS — MoCA in clinical practice (Curr Alzheimer Res 2014;11:330-344) — Current Alzheimer Research
  5. Alzheimer's Association — Cognitive Assessment Toolkit (2017) — Alzheimer's Association